Haisco Pharmaceutical Group Co Ltd - ESG Rating & Company Profile powered by AI
Other corporations in the rating peer group for Haisco Pharmaceutical Group Co Ltd are shownin the table. This ESG rating for Haisco Pharmaceutical Group Co Ltd indicates the company's transparency towards the UN Sustainable Development Goals. The ESG rating covers seventeen UN Sustainable Development Goals including: 'Gender Equality', 'Decent Work & Economic Growth' and 'Life on Land'.
Haisco Pharmaceutical Group Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | Haisco Pharmaceutical Group Co Ltd | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Haisco Pharmaceutical Group Co Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Haisco Pharmaceutical Group Co Ltd disclose current and historical energy intensity?
Does Haisco Pharmaceutical Group Co Ltd report the average age of the workforce?
Does Haisco Pharmaceutical Group Co Ltd reference operational or capital allocation in relation to climate change?
Does Haisco Pharmaceutical Group Co Ltd disclose its ethnicity pay gap?
Does Haisco Pharmaceutical Group Co Ltd disclose cybersecurity risks?
Does Haisco Pharmaceutical Group Co Ltd offer flexible work?
Does Haisco Pharmaceutical Group Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Haisco Pharmaceutical Group Co Ltd disclose the number of employees in R&D functions?
Does Haisco Pharmaceutical Group Co Ltd conduct supply chain audits?
Does Haisco Pharmaceutical Group Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Haisco Pharmaceutical Group Co Ltd conduct 360 degree staff reviews?
Does Haisco Pharmaceutical Group Co Ltd disclose the individual responsible for D&I?
Does Haisco Pharmaceutical Group Co Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Haisco Pharmaceutical Group Co Ltd disclose current and / or historical scope 2 emissions?
Does Haisco Pharmaceutical Group Co Ltd disclose water use targets?
Does Haisco Pharmaceutical Group Co Ltd have careers partnerships with academic institutions?
Did Haisco Pharmaceutical Group Co Ltd have a product recall in the last two years?
Does Haisco Pharmaceutical Group Co Ltd disclose incidents of discrimination?
Does Haisco Pharmaceutical Group Co Ltd allow for Work Councils/Collective Agreements to be formed?
Has Haisco Pharmaceutical Group Co Ltd issued a profit warning in the past 24 months?
Does Haisco Pharmaceutical Group Co Ltd disclose parental leave metrics?
Does Haisco Pharmaceutical Group Co Ltd disclose climate scenario or pathway analysis?
Does Haisco Pharmaceutical Group Co Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Haisco Pharmaceutical Group Co Ltd disclose the pay ratio of women to men?
Does Haisco Pharmaceutical Group Co Ltd support suppliers with sustainability related research and development?
Does Haisco Pharmaceutical Group Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Haisco Pharmaceutical Group Co Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Haisco Pharmaceutical Group Co Ltd involved in embryonic stem cell research?
Does Haisco Pharmaceutical Group Co Ltd disclose GHG and Air Emissions intensity?
Does Haisco Pharmaceutical Group Co Ltd disclose its waste policy?
Does Haisco Pharmaceutical Group Co Ltd report according to TCFD requirements?
Does Haisco Pharmaceutical Group Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Haisco Pharmaceutical Group Co Ltd disclose energy use targets?
Does Haisco Pharmaceutical Group Co Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Haisco Pharmaceutical Group Co Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Haisco Pharmaceutical Group Co Ltd
These potential risks are based on the size, segment and geographies of the company.
Haisco Pharmaceutical Group Co., Ltd., together with its subsidiaries, develops, produces, and sells drugs in China. The company offers small-volume injections, freeze-dried powder injections, powder injections, large-volume injections, active pharmaceutical ingredient, etc. for various therapeutic fields, including anti-infective, digestive system, blood system, nervous system, parenteral nutrition, antibiotics, first aid, anesthetics, and tumor; and tablets, capsules, granules, and ointments in the fields of cardiovascular, anti-infection, digestive system, CNS system, diabetes, and hepatic diseases. The company was formerly known as Xizang Haisco Pharmaceutical Group Co., Ltd. and changed its name to Haisco Pharmaceutical Group Co., Ltd. in March 2016. Haisco Pharmaceutical Group Co., Ltd. was founded in 2000 and is based in Shannan, China.